FindTrial
Sign In

Clinical randomized controlled trial of Clostridium butyricum in treatment of infantile viral diarrhea

Clinical randomized controlled trial of Clostridium butyricum in treatment of infantile viral diarrhea

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101133
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral diarrhea

Interventions

Placebo group:Take a placebo
Probiotic group:Oral Probiotic

Sponsors

Jingdezhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with pediatric viral diarrhea. 2. Age between 0-6 years old. 3. No serious complications and comorbidities requiring special treatment. 4. Parents or guardians sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to Clostridium butyricum. 2. High fever persists, and there is secondary diarrhea. 3. Patients with other serious diseases. 4. Those who have recently used other probiotics or antibacterial drugs.

Design outcomes

Primary

MeasureTime frame
Immunoglobulin;Composition of gut microbiota;—

Countries

China

Contacts

Public ContactXuewei Lei

Jingdezhen Second People's Hospital

13879806471@163.com+86 138 7980 6471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026